About

About ABclonal Technology ABclonal Technology accelerates the accuracy and precision of cancer research through our comprehensive catalog of high-quality, personalized reagents and services. Our innovative SMab™ technology, the first antibody discovery platform using single primary B cell ex vivo expansion, has produced PathoQ® for precision pathological immunohistochemistry, ABflo® for superior flow cytometry, and custom antibodies for novel targets. Our quantitative PCR mixes and kits marry cost effectiveness with superior results for your genomic analysis. Our versatile research tools cover targets impacting the study of apoptosis, autophagy, metabolism, metastasis, immune evasion, and more, with the ability to analyze tumor biology at multiple levels. Please visit abclonal.com for product information and quote requests.